Please Wait

Applying Filters...

CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

Data Compilation
#PharmaFlow

Pipeline Prospector September 2025: Genmab buys Merus for ~US$ 8 billion, Pfizer buys Metsera to enter obesity race

Stock Recap
#PipelineProspector

Levalbuterol Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

21 API Suppliers, 7 USDMF, 2 EU WC, 5 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

31 FDF Dossiers, 31 FDA Orange Book

DRUG PRODUCT COMPOSITIONS

SOLUTION;INHALATION - EQ 0.0103% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INHALATION - EQ 0.021% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INHALATION - EQ 0.042% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INHALATION - EQ 0.25% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Kirsch Pharma, 5 Actylis

EXCIPIENTS BY APPLICATIONS

5 Parenteral, 2 Controlled & Modified Release, 1 Thickeners and Stabilizers

DIGITAL CONTENT

7 News #PharmaBuzz

7 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions, 5 Regulatory FDF Prices, 5 Annual Reports

MARKET PLACE

3 APIs

3 APIs

REF. STANDARDS & IMPURITIES

2 Others

2 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Labeler	NDC Package Code	Non Proprietary Name	Start Marketing Date	End Marketing Date	Category Code	Dosage Form (Strength)
31/10/2025	Fine Chemicals Corporation PTY Ltd	South Africa	Fine Chemicals Corporation (PTY) Ltd.	48954-719	Levalbuterol Hydrochloride	2005-04-01	2025-12-31	BULK INGREDIENT	POWDER (1kg/kg)
31/10/2025	Aarti Pharmalabs	India	Aarti Pharmalabs Limited	15308-0310	Levalbuterol Hydrochloride	2000-01-01	2025-12-31	BULK INGREDIENT	POWDER (1kg/kg)

Contact us
to update this info

Levalbuterol Hydrochloride

Levalbuterol Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

21 API Suppliers

7 USDMF

2 EU WC

5 NDC API

15 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

31 FDF Dossiers

31 FDA Orange Book

DRUG PRODUCT COMPOSITIONS

SOLUTION;INHALATION - EQ 0.0103% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INHALATION - EQ 0.021% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INHALATION - EQ 0.042% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INHALATION - EQ 0.25% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Kirsch Pharma

5 Actylis

EXCIPIENTS BY APPLICATIONS

5 Parenteral

2 Controlled & Modified Release

1 Thickeners and Stabilizers

DIGITAL CONTENT

7 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions

5 Regulatory FDF Prices

5 Annual Reports

MARKET PLACE

3 APIs

REF. STANDARDS & IMPURITIES

2 Others

Filters

SOLUTION;INHALATION - EQ 0.0103% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INHALATION - EQ 0.021% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INHALATION - EQ 0.042% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INHALATION - EQ 0.25% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons